Wissenschaftliche Arbeiten

Doç. Dr. Berkan Armağan

299 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis

    Rheumatology international, 2023

    DOI 10.1007/s00296-022-05213-1 PMID 36129541 13 Zitationen (Europe PMC) Quelle: Europe PMC

  2. Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis

    Clinical and Experimental Rheumatology, 2023

    DOI 10.55563/clinexprheumatol/p1r1j4 PMID 38019154 11 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  3. Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome

    Clinical and Experimental Rheumatology, 2023

    DOI 10.55563/clinexprheumatol/pmbay6 PMID 38019164 8 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  4. Does decision tree analysis predict oral ulcer activity-related factors in patients with Behçet's syndrome?

    Clinical and Experimental Rheumatology, 2023

    DOI 10.55563/clinexprheumatol/5kr2b1 PMID 37902270 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  5. AB1376 CENTRAL SENSITIZATION IN AUTOIMMUNE CONNECTIVE TISSUE DISEASES: IS IT RELATED TO DISEASE ACTIVITY, COEXISTING FIBROMYALGIA, AND LABORATORY FINDINGS?

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.5478 Frei zugänglicher VolltextQuelle: OpenAlex

  6. CENTRAL SENSITIZATION IN AUTOIMMUNE CONNECTIVE TISSUE DISEASES: IS IT RELATED TO DISEASE ACTIVITY, COEXISTING FIBROMYALGIA, AND LABORATORY FINDINGS?

    AYBU AVESIS, 2023

    Quelle: OpenAlex

  7. Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022

    DOI 10.55730/1300-0144.5487 PMID 36422492 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  8. Hydroxychloroquine shortened hospital stay and reduced intensive care unit admissions in hospitalized COVID-19 patients

    The Journal of Infection in Developing Countries, 2022

    DOI 10.3855/jidc.14933 PMID 35192518 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  9. Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature review

    Immunotherapy, 2022

    DOI 10.2217/imt-2021-0128 PMID 35152720 11 Zitationen (Europe PMC) Quelle: Europe PMC

  10. Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience

    Future virology, 2022

    DOI 10.2217/fvl-2021-0146 PMID 35747325 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  11. Effects of anti-SARS-CoV-2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort

    International journal of rheumatic diseases, 2022

    DOI 10.1111/1756-185x.14387 PMID 35851753 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  12. Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial

    Human vaccines & immunotherapeutics, 2022

    DOI 10.1080/21645515.2022.2122503 PMID 36315843 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  13. Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease

    Rheumatology, 2022

    DOI 10.1093/rheumatology/keac005 PMID 35015853 12 Zitationen (OpenAlex) Quelle: OpenAlex

  14. The clinical significance of antiphospholipid antibodies in COVID-19 infection

    The Journal of Infection in Developing Countries, 2022

    DOI 10.3855/jidc.15423 PMID 35298422 9 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  15. A single‐center COVID ‐19 vaccine experience with CoronaVac and BNT162b2 in familial Mediterranean fever patients

    International Journal of Rheumatic Diseases, 2022

    DOI 10.1111/1756-185x.14349 PMID 35642453 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  16. COVID-19 outcomes in patients with antiphospholipid syndrome: a retrospective cohort study

    Bratislavské lekárske listy/Bratislava medical journal, 2022

    DOI 10.4149/bll_2022_018 PMID 35065587 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  17. Intravenous treatment adherence of patients with chronic inflammatory rheumatic diseases during the COVID-19 pandemic: experience of a single center

    Romanian Journal of Internal Medicine, 2022

    DOI 10.2478/rjim-2022-0010 PMID 35766218 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  18. COVID-19 course in granulomatosis with polyangiitis: single center experience with review of the literature

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022

    DOI 10.55730/1300-0144.5389 PMID 36326380 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  19. Reducing length of hospital stay with colchicine

    The Journal of Infection in Developing Countries, 2022

    DOI 10.3855/jidc.14924 PMID 35192522 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  20. Evaluation of Coronavirus Disease-2019 Patients with Nailfold Capillaroscopy

    Namık Kemal Tıp Dergisi, 2022

    DOI 10.4274/nkmj.galenos.2021.97269 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  21. Restless leg syndrome and sleep quality in granulomatosis with polyangiitis

    Ulusal Romatoloji Dergisi, 2022

    DOI 10.4274/raed.galenos.2022.36035 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  22. Antineutrophil Cytoplasmic Antibody Positivity and Clinical Implications in COVID-19

    Future Virology, 2022

    DOI 10.2217/fvl-2021-0125 PMID 35173795 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  23. AB1142 EFFECTS OF SULFASALAZINE USED IN AXIAL SPONDYLOARTHRITIS ON COVID-19 OUTCOMES: REAL-LIFE DATA FROM A SINGLE CENTER

    Annals of the Rheumatic Diseases, 2022

    DOI 10.1136/annrheumdis-2022-eular.3685 Frei zugänglicher VolltextQuelle: OpenAlex

  24. POS1274 A SINGLE CENTER COVID-19 VACCINE EXPERIENCE IN FAMILIAL MEDITERRANEAN FEVER PATIENTS

    Annals of the Rheumatic Diseases, 2022

    DOI 10.1136/annrheumdis-2022-eular.4920 Frei zugänglicher VolltextQuelle: OpenAlex

  25. POS1250 EVALUATION AFTER COVID-19 VACCINATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: A RETROSPECTIVE COHORT STUDY.

    Annals of the Rheumatic Diseases, 2022

    DOI 10.1136/annrheumdis-2022-eular.3542 Frei zugänglicher VolltextQuelle: OpenAlex

  26. POS1280 EFFECTS OF ANTI-SARS-CoV-2 VACCINATION ON SAFETY AND DISEASE EXACERBATION IN BEHCET'S DISEASE PATIENTS: A SINGLE CENTRE STUDY

    Annals of the Rheumatic Diseases, 2022

    DOI 10.1136/annrheumdis-2022-eular.5125 Frei zugänglicher VolltextQuelle: OpenAlex

  27. Neurological involvoment in patients with primary Sjögren syndome: A retrospective cross-sectional study

    AYBU AVESIS, 2022

    Quelle: OpenAlex

  28. Romatoloji pratiğinde PET/BT tecrübesi ve tanısal değeri ile ilişkili faktörlerin incelenmesi

    AYBU AVESIS, 2022

    Quelle: OpenAlex

  29. Antibodies to Both Ro52 and Ro60 for Identifying Sjögren's Syndrome Patients Best Suited for Clinical Trials of Disease-Modifying Therapies

    Arthritis care & research, 2022

    DOI 10.1002/acr.24597 PMID 33742788 23 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  30. Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study

    Rheumatology advances in practice, 2022

    DOI 10.1093/rap/rkac071 PMID 36133962 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  31. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies

    Rheumatology (Oxford, England), 2022

    DOI 10.1093/rheumatology/keac205 PMID 35385104 16 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  32. Association between oxygen delivery and digital ulcers in systemic sclerosis

    Microvascular Research, 2022

    DOI 10.1016/j.mvr.2022.104449 PMID 36374796 2 Zitationen (OpenAlex) Quelle: OpenAlex

  33. Effects of COVID-19 on axial spondyloarthritis disease flare

    Gulhane Medical Journal, 2022

    DOI 10.4274/gulhane.galenos.2022.93723 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  34. The relationship between malignancy and Behçet's disease features

    Journal of Health Sciences and Medicine, 2022

    DOI 10.32322/jhsm.1063623 Frei zugänglicher VolltextQuelle: OpenAlex

  35. EVALUATION OF QUALITY OF LIFE SCALES ACCORDING TO DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS

    Acibadem Universitesi Saglik Bilimleri Dergisi, 2022

    DOI 10.31067/acusaglik.1032580 Frei zugänglicher VolltextQuelle: OpenAlex

  36. AB0592 IS IT TIME TO DISSECTING GIANT CELL ARTERITIS INTO SUBPHENOTYPES? A CLOSE LOOK TO DATA OF EASTERN MEDITERRANEAN VASCULITIS CENTRE

    Annals of the Rheumatic Diseases, 2022

    DOI 10.1136/annrheumdis-2022-eular.3035 Frei zugänglicher VolltextQuelle: OpenAlex

  37. AB1175 EFFECTS OF THE COVID-19 DISEASE ON AXIAL SPONDYLOARTHRITIS DISEASE FLARE

    Annals of the Rheumatic Diseases, 2022

    DOI 10.1136/annrheumdis-2022-eular.4769 Frei zugänglicher VolltextQuelle: OpenAlex

  38. Comment on: What is the meaning of ANCA positivity in IgG4-related disease?

    Rheumatology (Oxford, England), 2021

    DOI 10.1093/rheumatology/keab356 PMID 33871599 Quelle: Europe PMC

  39. COVID-19 in patients with Behçet’s disease: Outcomes and rate of Behçet’s exacerbations in a retrospective cohort

    Modern Rheumatology, 2021

    DOI 10.1093/mr/roab016 PMID 34910209 12 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  40. Prevalence of sarcopenia and clinical implications in patients with newly diagnosed rheumatoid arthritis

    Nutrition, 2021

    DOI 10.1016/j.nut.2021.111353 PMID 34192633 18 Zitationen (OpenAlex) Quelle: OpenAlex

  41. COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-04812-8 PMID 33611656 15 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  42. COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-04896-2 PMID 34032896 9 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  43. A single center experience of intravenous immunoglobulin treatment in Covid-19

    International Immunopharmacology, 2021

    DOI 10.1016/j.intimp.2021.107891 PMID 34153671 9 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  44. Semaphorin 3A Levels in Lupus with and without Secondary Antiphospholipid Antibody Syndrome and Renal Involvement

    Laboratory Medicine, 2021

    DOI 10.1093/labmed/lmab096 PMID 34927690 2 Zitationen (OpenAlex) Quelle: OpenAlex

  45. AB0314 SEMAPHORIN 3A LEVELS IN LUPUS WITH AND WITHOUT SECONDARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME AND RENAL INVOLVEMENT

    Annals of the Rheumatic Diseases, 2021

    DOI 10.1136/annrheumdis-2021-eular.1864 1 Zitation (OpenAlex) Quelle: OpenAlex

  46. AB0157 PREVALENCE OF SARCOPENIA AND CLINICAL IMPLICATIONS IN NEWLY DIAGNOSED RHEUMATOID ARTHRITIS PATIENTS

    Annals of the Rheumatic Diseases, 2021

    DOI 10.1136/annrheumdis-2021-eular.1874 Frei zugänglicher VolltextQuelle: OpenAlex

  47. AB0200 TRENDS IN THE CHOICE OF FIRST BIOLOGIC AND TARGETED SYNTHETIC DMARD IN RHEUMATOID ARTHRITIS PATIENTS: 20-YEARS JOURNEY OF HUR-BIO REAL-LIFE REGISTRY

    Annals of the Rheumatic Diseases, 2021

    DOI 10.1136/annrheumdis-2021-eular.693 1 Zitation (OpenAlex) Quelle: OpenAlex

  48. AB0201 CHANGES IN THE PRESCRIPTION PATTERNS OF THE SECOND-LINE BIOLOGIC AND TARGETED SYNTHETIC DMARD IN RHEUMATOID ARTHRITIS PATIENTS: 20-YEARS JOURNEY OF HUR-BIO REAL-LIFE REGISTRY

    Annals of the Rheumatic Diseases, 2021

    DOI 10.1136/annrheumdis-2021-eular.694 Frei zugänglicher VolltextQuelle: OpenAlex

  49. Childhood-onset of primary Sjögren’s syndrome: phenotypic characterization at diagnosis of 158 children

    Rheumatology, 2021

    DOI 10.1093/rheumatology/keab032 PMID 33493333 80 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  50. Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium

    Clinical and Experimental Rheumatology, 2021

    DOI 10.55563/clinexprheumatol/egnd1i PMID 34919044 16 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex